ES2173626T3 - Metodos y composiciones para tratar la artritis reumatoide. - Google Patents
Metodos y composiciones para tratar la artritis reumatoide.Info
- Publication number
- ES2173626T3 ES2173626T3 ES98948455T ES98948455T ES2173626T3 ES 2173626 T3 ES2173626 T3 ES 2173626T3 ES 98948455 T ES98948455 T ES 98948455T ES 98948455 T ES98948455 T ES 98948455T ES 2173626 T3 ES2173626 T3 ES 2173626T3
- Authority
- ES
- Spain
- Prior art keywords
- carbonyl
- methylprolyl
- residue
- tert
- isoleucyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Uso, para la fabricación de un medicamento para el tratamiento de la artritis reumatoide en un mamífero, de un compuesto de Fórmula I: R 1 R 2 N-CHX-CO-A-B-D-(E)s-(F)t-(G)u-K (I) en la que: R 1 es alquilo, cicloalquilo, alquilsulfonilo, fluoroalquilo o aminosulfonilo; R 2 es hidrógeno, alquilo,fluoroalquilo o cicloalquilo; R 1 -N-R 2 juntos pueden ser un residuo de pirrolidino o piperidino; A es un residuo de valilo, isoleucilo, leucilo, alo-isoleucilo, 2,2-dimetilglicilo, 2-ciclopropilglicilo, 2-ciclopentilglicilo, 3-terc-butilalanilo, 2-terc-butilglicilo, 3-ciclohexilalanilo, 2-etilglicilo, 2-ciclohexilglicilo, norleucilo o norvalilo; B es un residuo de N-alquil-valilo, -norvalilo, -leucilo, -isoleucilo, -2-terc-butilglicilo, -3-terc-butilalanilo, -2-etilglicilo, -2-ciclopropilglicilo, -2-ciclopentilglicilo, -norleucilo o -2-ciclohexilglicilo; D es un residuo de prolilo, homoprolilo, hidroxiprolilo, 3,4-deshidroprolilo, 4uoroprolilo, 3-metilprolilo, 4-metilprolilo, 5-metilprolilo, azetidin-2-carbonilo, 3,3-dimetilprolilo, 4,4-di fluoroprolilo, oxazolidin4-carbonilo o tiazolidin-4-carbonilo; E es un residuo de prolilo, homoprolilo, hidroxiprolilo, 3,4-deshidroprolilo, 4uoroprolilo, 3-metilprolilo, 4-metilprolilo, 5-metilprolilo, azetidin-2-carbonilo, 3,3-dimetilprolilo, 4,4-di uoroprolilo, oxazolidin4-carbonilo o tiazolidin-4-carbonilo; F y G se seleccionan independientemente del grupo que consiste en residuos de prolilo, homoprolilo, hidroxiprolilo, tiazolidinil-4-carbonilo, 1-aminopentil-1-carbonilo, valilo, 2-terc-butilglicilo, isoleucilo, leucilo, 3-ciclohexilalanilo, fenilalanilo, N-metilfenilalanilo, tetrahidroisoquinolil-2-histidilo, 1-aminoindil-1-carbonilo, 3-piridilalanilo, 2-ciclohexilglicilo, norleucilo, norvalilo, neopentilglicilo, triptofanilo, glicilo, 2,2-dimetilglicilo, alanilo, -alanilo y 3-naftilalanilo; X eshidrógeno, alquilo, cicloalquilo, -CH2-ciclohexilo o arilalquilo; s, t y u son independientemente 0 ó 1;y K es hidroxi, alcoxi, fenoxi, benciloxi o unresto amino sustituido o no sustituido; y las sales del mismo con ácidos fisiológicamente tolerados.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/944,479 US6015790A (en) | 1997-10-06 | 1997-10-06 | Methods and compositions for treating rheumatoid arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2173626T3 true ES2173626T3 (es) | 2002-10-16 |
Family
ID=25481479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98948455T Expired - Lifetime ES2173626T3 (es) | 1997-10-06 | 1998-09-24 | Metodos y composiciones para tratar la artritis reumatoide. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6015790A (es) |
| EP (1) | EP1021200B1 (es) |
| JP (1) | JP2001518515A (es) |
| KR (1) | KR20010081900A (es) |
| CN (1) | CN1278734A (es) |
| AR (1) | AR017298A1 (es) |
| AT (1) | ATE212855T1 (es) |
| AU (2) | AU748465B2 (es) |
| BG (1) | BG104292A (es) |
| BR (1) | BR9812875A (es) |
| CA (1) | CA2305688A1 (es) |
| DE (1) | DE69803792D1 (es) |
| DK (1) | DK1021200T3 (es) |
| ES (1) | ES2173626T3 (es) |
| HR (1) | HRP20000265A2 (es) |
| HU (1) | HUP0101715A3 (es) |
| IL (1) | IL135167A0 (es) |
| NO (1) | NO20001758L (es) |
| PL (1) | PL339731A1 (es) |
| PT (1) | PT1021200E (es) |
| SK (1) | SK4272000A3 (es) |
| TR (1) | TR200000903T2 (es) |
| WO (2) | WO1999017792A1 (es) |
| ZA (1) | ZA989036B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010009901A1 (en) * | 1996-12-11 | 2001-07-26 | Basf Aktiengesellschaft Germany | Antineoplastic peptides |
| KR100261114B1 (ko) * | 1998-01-24 | 2000-07-01 | 박종헌 | 히스톤을 함유하는 류마티스 관절염 치료제 조성물 |
| WO2001019390A1 (en) * | 1999-09-14 | 2001-03-22 | Pfizer Products Inc. | Combination treatment with il-1ra and diaryl sulphonyl urea compounds |
| AU1730701A (en) * | 1999-12-07 | 2001-06-18 | Santen Pharmaceutical Co. Ltd. | Rheumatism remedy containing tetrapeptide derivative as active ingredient |
| WO2001047886A1 (en) | 1999-12-24 | 2001-07-05 | F. Hoffmann-La Roche Ag | Nitrile derivatives as cathepsin k inhibitors |
| BRPI0720884A2 (pt) * | 2007-01-09 | 2014-03-25 | Bayer Schering Pharma Ag | Radiorrotulação por meio de fluoração de aziridinas |
| EP2443136A4 (en) | 2009-06-18 | 2013-01-09 | Strongbone Ab | NOVEL PEPTIDE DERIVATIVES FOR TREATMENT, PREVENTION OR MITIGATION OF AFFECTION ASSOCIATED WITH BONE LOSS OR LOW BONE DENSITY OR INHIBITING DIFFERENTIATION AND STIMULATION OF OSTEOCLASTS |
| BR112015016580A2 (pt) * | 2013-01-11 | 2017-07-11 | Fujifilm Corp | composto heterocíclico contendo nitrogênio ou sal deste |
| KR102372512B1 (ko) * | 2017-11-20 | 2022-03-10 | 가톨릭대학교 산학협력단 | 폴리감마글루탐산 및 메토트렉세이트를 유효성분으로 포함하는 관절염 예방 또는 치료용 조성물 |
| CN115281149A (zh) * | 2021-05-12 | 2022-11-04 | 四川大学华西医院 | 一种临床前类风湿关节炎(Pre-RA)小鼠模型 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816444A (en) * | 1987-07-10 | 1989-03-28 | Arizona Board Of Regents, Arizona State University | Cell growth inhibitory substance |
| US4879278A (en) * | 1989-05-16 | 1989-11-07 | Arizona Board Of Regents | Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15 |
| DK0934950T3 (da) * | 1991-08-09 | 2002-07-29 | Teikoku Hormone Mfg Co Ltd | Tetrapeptidderivat |
| US5831002A (en) * | 1992-05-20 | 1998-11-03 | Basf Aktiengesellschaft | Antitumor peptides |
| HUT72067A (en) * | 1992-12-16 | 1996-03-28 | Basf Ag | Dolostatin analog |
| US5530097A (en) * | 1994-08-01 | 1996-06-25 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory peptide amides |
| US5504191A (en) * | 1994-08-01 | 1996-04-02 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide methyl esters |
| US5583153A (en) * | 1994-10-06 | 1996-12-10 | Regents Of The University Of California | Use of taxol in the treatment of rheumatoid arthritis |
-
1997
- 1997-10-06 US US08/944,479 patent/US6015790A/en not_active Expired - Fee Related
-
1998
- 1998-09-24 IL IL13516798A patent/IL135167A0/xx unknown
- 1998-09-24 AT AT98948455T patent/ATE212855T1/de not_active IP Right Cessation
- 1998-09-24 DK DK98948455T patent/DK1021200T3/da active
- 1998-09-24 WO PCT/US1998/019841 patent/WO1999017792A1/en not_active Application Discontinuation
- 1998-09-24 DE DE69803792T patent/DE69803792D1/de not_active Expired - Fee Related
- 1998-09-24 CN CN98811034A patent/CN1278734A/zh active Pending
- 1998-09-24 TR TR2000/00903T patent/TR200000903T2/xx unknown
- 1998-09-24 SK SK427-2000A patent/SK4272000A3/sk unknown
- 1998-09-24 EP EP98948455A patent/EP1021200B1/en not_active Expired - Lifetime
- 1998-09-24 KR KR1020007003706A patent/KR20010081900A/ko not_active Application Discontinuation
- 1998-09-24 BR BR9812875-2A patent/BR9812875A/pt not_active IP Right Cessation
- 1998-09-24 ES ES98948455T patent/ES2173626T3/es not_active Expired - Lifetime
- 1998-09-24 AU AU95024/98A patent/AU748465B2/en not_active Ceased
- 1998-09-24 CA CA002305688A patent/CA2305688A1/en not_active Abandoned
- 1998-09-24 HU HU0101715A patent/HUP0101715A3/hu unknown
- 1998-09-24 PT PT98948455T patent/PT1021200E/pt unknown
- 1998-09-24 JP JP2000514663A patent/JP2001518515A/ja not_active Withdrawn
- 1998-09-24 PL PL98339731A patent/PL339731A1/xx not_active Application Discontinuation
- 1998-09-30 WO PCT/US1998/020465 patent/WO1999017709A2/en active Application Filing
- 1998-09-30 AU AU95926/98A patent/AU9592698A/en not_active Withdrawn
- 1998-10-05 ZA ZA9809036A patent/ZA989036B/xx unknown
- 1998-10-06 AR ARP980104972A patent/AR017298A1/es not_active Application Discontinuation
-
2000
- 2000-04-03 BG BG104292A patent/BG104292A/xx unknown
- 2000-04-05 NO NO20001758A patent/NO20001758L/no not_active Application Discontinuation
- 2000-05-04 HR HR20000265A patent/HRP20000265A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1021200A1 (en) | 2000-07-26 |
| PT1021200E (pt) | 2002-07-31 |
| DE69803792D1 (de) | 2002-03-21 |
| IL135167A0 (en) | 2001-05-20 |
| NO20001758L (no) | 2000-06-05 |
| JP2001518515A (ja) | 2001-10-16 |
| HRP20000265A2 (en) | 2000-12-31 |
| KR20010081900A (ko) | 2001-08-29 |
| NO20001758D0 (no) | 2000-04-05 |
| BR9812875A (pt) | 2000-08-08 |
| BG104292A (en) | 2000-12-29 |
| EP1021200B1 (en) | 2002-02-06 |
| PL339731A1 (en) | 2001-01-02 |
| CN1278734A (zh) | 2001-01-03 |
| TR200000903T2 (tr) | 2001-07-23 |
| US6015790A (en) | 2000-01-18 |
| HUP0101715A3 (en) | 2001-12-28 |
| ATE212855T1 (de) | 2002-02-15 |
| WO1999017709A2 (en) | 1999-04-15 |
| AR017298A1 (es) | 2001-09-05 |
| HUP0101715A2 (hu) | 2001-11-28 |
| ZA989036B (en) | 2000-04-05 |
| WO1999017792A1 (en) | 1999-04-15 |
| AU9502498A (en) | 1999-04-27 |
| AU9592698A (en) | 1999-04-27 |
| CA2305688A1 (en) | 1999-04-15 |
| DK1021200T3 (da) | 2002-05-27 |
| SK4272000A3 (en) | 2001-02-12 |
| AU748465B2 (en) | 2002-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR003136A1 (es) | Peptidos de dolastatin, procedimiento para prepararlos, las composiciones farmaceuticas que los contienen y el uso de los mismos para preparar dichas composiciones farmaceuticas. | |
| AR002043A1 (es) | Utilizacion de agonistas de alfa (1l) para el tratamiento de la incontinencia urinaria. | |
| BR9406779A (pt) | Complexos de inclusão de multicomponentes altamente solúveis contendo uma droga de tipo básico um ácido e uma ciclodextrina | |
| DK0799209T3 (da) | Sulfonamider | |
| AR023529A1 (es) | Una composicion champu acondicionadora del cabello y un metodo para acondicionar el cabello | |
| ES2173626T3 (es) | Metodos y composiciones para tratar la artritis reumatoide. | |
| AR018501A1 (es) | Derivados de la dolastatina 15 | |
| TR199903191T2 (xx) | Vorikonazol i�eren ila� form�lasyonlar�. | |
| BR9609393A (pt) | Composição injetável de colágeno; segmentos de fibra de colágeno reconstituìdos. | |
| IS2833B (is) | 1,5 Bensóþíósepín og notkun þeirra gegn fitublæði | |
| BG104679A (en) | The use of fumaric acid derivatives in transplant medicine | |
| HUP0301842A2 (hu) | Laktám vegyület, a vegyületet tartalmazó gyógyszerkészítmény és alkalmazása gyógyszerkészítmény elżállítására | |
| BR0210322A (pt) | Composição limpadora perolada para cuidado pessoal | |
| NO20021281D0 (no) | Vaskul¶r beleggingssammensetning | |
| AR011957A1 (es) | Derivados de dolastatina 15 con funcionalidades carbonilo y heterociclicas en el c-terminal | |
| CO5540368A2 (es) | Composicion de liberacion sostenida y proceso para producirla | |
| DE60233261D1 (de) | Inhibitoren von humanem adam-10 | |
| BR0304298A (pt) | Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume | |
| DE69420145D1 (de) | Behandlung präkanzeröser läsionen durch muramylpeptide | |
| AR040441A1 (es) | Compuesto de tiol, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento, procedimiento para prepararlo y compuesto intermediario de utilidad en dicho procedimiento | |
| ES8105865A1 (es) | Un procedimiento para la determinacion cuantitativa de enzi-mas proteoliticas | |
| HUP0202379A2 (hu) | Új vegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| UY26911A1 (es) | Ácidos amino (oxo) acéticos inhibidores de la proteina tirosina fosfatasa | |
| ES2110057T3 (es) | Composicion medicinal que contiene tcf-ii. | |
| BRPI0414812A (pt) | método de inibir a expressão de genes resistentes a múltiplos medicamentos e de inibir a produção de proteìnas resultantes da expressão de tais gene, melhorando assim a efetividade dos agentes quimioterápicos para tratar cánceres |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 1021200 Country of ref document: ES |